About National Hospital Organization Himeji Medical Center
独立行政法人国立病院機構姫路医療センターは、兵庫県姫路市にある医療機関。独立行政法人国立病院機構が運営する病院である。旧国立姫路病院。姫路城の東に位置する。政策医療分野におけるがん、循環器病、成育医療、骨・運動器疾患の専門医療施設であり、地域がん診療連携拠点病院、エイズ治療拠点病院などの指定を受ける。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at National Hospital Organization Himeji Medical Center
During the past decade, National Hospital Organization Himeji Medical Center conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 9 clinical trials were completed, i.e. on
average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Hospital Organization Himeji Medical Center" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Boehringer Ingelheim" with 5 trials
sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Actelion" with 2 trials sponsored and "Bayer"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Himeji Medical Center"
#1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at National Hospital Organization Himeji Medical Center
According to Clinical.Site data, the most researched conditions in "National Hospital Organization Himeji Medical Center" are
"Idiopathic Pulmonary Fibrosis" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Lung Diseases, Interstitial" (3 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "National Hospital Organization Himeji Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at National Hospital Organization Himeji Medical Center
Most popular intervention types in "National Hospital Organization Himeji Medical Center" are "Drug" (32 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (8 trials), "Nintedanib" (5 trials), "Pemetrexed" (5 trials) and "Amivantamab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at National Hospital Organization Himeji Medical Center
The vast majority of trials in "National Hospital Organization Himeji Medical Center" are
36 trials for "All" genders.
Clinical Trials Status at National Hospital Organization Himeji Medical Center
Currently, there are NaN active trials in "National Hospital Organization Himeji Medical Center".
undefined are not yet recruiting,
9 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in National Hospital Organization Himeji Medical Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Himeji Medical Center, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".